ABOUT CONFERENCE
ConferenceSeries LLC Ltd invites every one throughout the world to attend the “17th World Congress on Dementia & Alzheimer’s Disease” during October 19-20, 2020 at Vienna, Austria which includes Keynote speeches, Oral talks, Poster presentations, and Exhibitions.
Summary:
Neuroscience is the logical investigation of the sensory system. It is a multidisciplinary part of science that joins physiology, life structures, atomic science, Dementia, formative science, cytology, numerical displaying and brain science to comprehend the central and eminent properties of neurons and neural circuits. Neurological disorders involve the spinal column or nerves, brain. The most common neurological disorders are Dementia and Alzheimer's.
Euro Dementia Congress 2020 is honored and delighted to welcome the Scientists, Neurologists, Neuro-physicians, Critical Care Specialists, Doctors, eminent professors, researchers, students, delegates and experts from all over the world to attend our conference. The conference is based on the theme “New Scientific Discoveries and Technologies in Dementia Research”, which will provide a global networking platform for all the attendees.
Importance & Scope:
Dementia is a general term that depicts a social affair of reactions, for instance, loss of memory, judgment, tongue, complex motor capacities, and other insightful limit caused by the enduring mischief or going of the cerebrum's nerve cells, or neurons. Dementia, including Alzheimer's disease, is one of the best overall general prosperity challenges standing up to our period.
All around, eventual outcomes of a current meta-examination prescribe that 44 million people lived with dementia worldwide in 2010, with numbers foreseen that would twofold at standard interim's, to 65.7 million of each 2030 and 115.4 million out of 2050. In 2010, 58 percent shockingly with dementia lived in countries with low or focus compensation, with this degree predicted to rise to 63 percent in 2030 and 71 percent in 2050. This number is depended upon to twofold by 2030 and more than triple by 2050 to 115 million.
In the United States alone, experts gage that upwards of five million people age 65 and more settled experience the evil impacts of Alzheimer's affliction The AD advertise has an absence of helpful alternatives. Which classes of medication overwhelm the market?
Conference Highlights
- Alzheimer’s Disease
- Dementia Lewy Body
- Vascular Dementia
- Neurological Diseases
- Neurology and Neurosurgery
- Neurodegenerative Diseases
- Neuropharmacology
- Neurovascular Dysfunction and Neurodegeneration
- Psychiatry Mental health disorders
- Neuroimaging Biomarkers
- Neuro Oncology and Central Nervous System
- Amyloid Protein in Dementia and Alzheimer’s
- Brain Diseases & Traumatic Brain Injury
- Dementia and Ageing
- Dementia Nursing
- Alzheimer’s and the Brain
- Alzheimer Disease and Cellular Mechanisms
- Alzheimer’s Clinical Trials and Studies
- Diagnostic Alzheimer
- Molecular Genetics and Biology of Dementia
- Novel Therapeutics Targets
Special Issues
- All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.
- All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.
- Abstracts will be provided with Digital Object Identifier by Cross Ref.
See more at: https://dementia.insightconferences.com/
See more at: https://dementia.insightconferences.com/
